XBIOTECH INC's ticker is XBIT and the CUSIP is 98400H102. A total of 50 filers reported holding XBIOTECH INC in Q4 2016. The put-call ratio across all filers is 2.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $8,000 | -80.0% | 439 | -80.4% | 0.00% | – |
Q4 2020 | $40,000 | +207.7% | 2,238 | +238.1% | 0.00% | – |
Q3 2020 | $13,000 | -23.5% | 662 | -42.0% | 0.00% | – |
Q2 2020 | $17,000 | -92.0% | 1,141 | -94.1% | 0.00% | – |
Q1 2020 | $213,000 | +373.3% | 19,475 | +714.9% | 0.00% | – |
Q4 2019 | $45,000 | +136.8% | 2,390 | +31.8% | 0.00% | – |
Q3 2019 | $19,000 | +58.3% | 1,814 | +17.5% | 0.00% | – |
Q2 2019 | $12,000 | +500.0% | 1,544 | +929.3% | 0.00% | – |
Q1 2019 | $2,000 | +100.0% | 150 | 0.0% | 0.00% | – |
Q4 2018 | $1,000 | – | 150 | 0.0% | 0.00% | – |
Q3 2018 | $0 | -100.0% | 150 | 0.0% | 0.00% | – |
Q2 2018 | $1,000 | 0.0% | 150 | 0.0% | 0.00% | – |
Q1 2018 | $1,000 | -99.6% | 150 | -99.8% | 0.00% | – |
Q4 2017 | $240,000 | -15.5% | 61,000 | -6.2% | 0.00% | – |
Q3 2017 | $284,000 | +20.3% | 65,000 | +30.0% | 0.00% | – |
Q2 2017 | $236,000 | -71.4% | 50,000 | 0.0% | 0.00% | – |
Q1 2017 | $824,000 | +243.3% | 50,000 | +190.7% | 0.00% | – |
Q4 2016 | $240,000 | +3.4% | 17,200 | 0.0% | 0.00% | – |
Q3 2016 | $232,000 | – | 17,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Virtus ETF Advisers LLC | 18,095 | $192,000 | 0.08% |
Paloma Partners Management Co | 24,496 | $260,000 | 0.02% |
CSS LLC/IL | 13,325 | $141,000 | 0.01% |
Cubist Systematic Strategies, LLC | 34,273 | $364,000 | 0.01% |
ALPS ADVISORS INC | 49,248 | $523,000 | 0.01% |
BALYASNY ASSET MANAGEMENT L.P. | 50,427 | $536,000 | 0.01% |
FORA Capital, LLC | 2,101 | $22,000,000 | 0.01% |
Squarepoint Ops LLC | 11,415 | $121,000 | 0.00% |
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 100,071 | $1,063,000 | 0.00% |
Russell Investments Group, Ltd. | 103,843 | $1,101,000 | 0.00% |